Pharming Group NV
NASDAQ:PHAR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharming Group NV
NASDAQ:PHAR
|
NL |
|
Orix Corp
F:OIX
|
JP |
|
Fujifilm Holdings Corp
TSE:4901
|
JP |
|
Q
|
Qantas Airways Ltd
F:QAN
|
AU |
|
L
|
LyondellBasell Industries NV
XBER:DLY
|
UK |
Wall St Price Targets
PHAR Price Targets Summary
Pharming Group NV
According to Wall Street analysts, the average 1-year price target for PHAR is 25.74 USD with a low forecast of 20.73 USD and a high forecast of 31.13 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHAR's stock price target?
Price Target
25.74
USD
According to Wall Street analysts, the average 1-year price target for PHAR is 25.74 USD with a low forecast of 20.73 USD and a high forecast of 31.13 USD.
What is the Revenue forecast for Pharming Group NV?
Projected CAGR
20%
Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 20%.
What is the Gross Profit forecast for Pharming Group NV?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 49%. The projected CAGR for the next 3 years is 0%.
What is the Operating Income forecast for Pharming Group NV?
Projected CAGR
36%
The compound annual growth rate for Operating Income over the next 5 years is 36%.
What is the Pre-Tax Income forecast for Pharming Group NV?
Projected CAGR
53%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.
What is the Net Income forecast for Pharming Group NV?
Projected CAGR
112%
The compound annual growth rate for Net Income over the next 5 years is 112%.
